<DOC>
	<DOCNO>NCT02244567</DOCNO>
	<brief_summary>High ucOC may favor insulin release lean hyperandrogenic woman compensate impaired insulin sensitivity . Meformin insulin sensitize agent give woman try interfere pathophysiology PCOS woman follow serum UC-OC level .</brief_summary>
	<brief_title>Effect Metformin Therapy Serum Under-carboxylated Osteocalcin Levels Hyperandrogenic Lean Polycystic Ovarian Syndrome Women</brief_title>
	<detailed_description>Under-carboxylated osteocalcin ( ucOC ) , precursor substrate bone biomarker OC potent regulator energy metabolism promote insulin production adiponectin synthesis decrease fat stores.UcOC potential role physiopathology polycystic ovary syndrome ( PCOS ) , common disorder define constellation anovulation , insulinresistance , hyperinsulinemia , obesity androgen excess.Circulating ucOC concentration relate key endocrine PCOS characteristic weight-dependent manner . Within bone-pancreas loop , high ucOC may favor insulin release lean hyperandrogenic woman compensate impaired insulin sensitivity.We investigate serum uc-OC response insulin sensitize therapy lean hyperandrogenic polycystic ovary syndrome ( PCOS ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Lean woman BMI 25 less Hyperandrogenic clinically and/or biochemically . Androgen ExcessPolycystic Ovary Syndrome ( AEPCOS ) Society 2006 criterion BMI 20 Other cause hyperandrogenism Other cause metabolic disorder diabetes .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>PCOS</keyword>
</DOC>